Publications
5 shownThe interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Summary: For the last four decades, the treatment of cancer has relied on four treatment modalities, namely surgery, radiotherapy, cytotoxic chemotherapy, and hormonotherapy. Mo...
Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
Treatment with alpelisib-fulvestrant prolonged progression-free survival among patients with <i>PIK3CA</i>-mutated, HR-positive, HER2-negative advanced breast cancer who had rec...
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Trastuzumab deruxtecan showed durable antitumor activity in a pretreated patient population with HER2-positive metastatic breast cancer. In addition to nausea and myelosuppressi...
Frequent Co-Authors
Researcher Info
- h-index
- 5
- Publications
- 5
- Citations
- 8,471
- Institution
- Laboratoire d'études sur les monothéismes
External Links
Identifiers
- ORCID
- 0000-0001-5795-8357
Impact Metrics
h-index
5
h-index: Number of publications with at least h citations each.